NCT03236662View on ClinicalTrials.gov

(-)- Epicatechin Becker Muscular Dystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2017

Conditions
Becker Muscular Dystrophy
Interventions
DRUG

(-)-Epicatechin

Trial Locations (1)

95817

UC Davis Medical Center, Sacramento

Sponsors
All Listed Sponsors
lead

Craig McDonald, MD

OTHER

collaborator

Cardero Therapeutics, Inc.

INDUSTRY